The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)
Author:
Funder
Programa Nacional de Apoio à Atenção Oncológica (PRONON) of the Brazilian Health Ministry (
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-020-05831-y.pdf
Reference26 articles.
1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
2. Instituto Nacional de Câncer José Alencar Gomes (2018) Estimativa 2018: Incidência de Câncer no Brasil. INCA, Rio de Janeiro
3. Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229
4. Goss PE, Lee BL, Badovinac-Crnjevic T et al (2013) Planning cancer control in Latin America and the Caribbean. Lancet Oncol 14:391–436. https://doi.org/10.1016/S1470-2045(13)70048-2
5. Simon SD, Bines J, Werutsky G et al (2019) Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: the AMAZONA retrospective cohort study. Breast 44:113–119
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of the genomic signature of 70-genes for breast cancer in the public system and in supplementary health care in a country of medium socioeconomic development;The Breast;2024-08
2. QSAR Based Drug Repurposing: A New Paradigm in Breast Cancer Research;Indian Journal of Pharmaceutical Education and Research;2024-06-21
3. Mapping breast and prostate cancer in the Brazilian public health system: study protocol of the Onco-Genomas Brasil;Frontiers in Oncology;2024-03-13
4. The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation;Revista Brasileira de Ginecologia e Obstetrícia;2024
5. Prognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World Study;Clinical Breast Cancer;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3